Acute asthma
Causes and risk factors
Management and prevention
Asthma in the ICU
Allergic Rhinitis Impact on Asthma
Pathophysiology of Allergic Rhinitis and Asthma
Impact of Allergic Rhinitis Therapies in Asthma
Allergen Immunotherapy in Asthma
Allergy
Allergy testing
Aero-allergens and airways
The ARIA initiative
Asthma and COPD
Influence of Tobacco on asthma
Is Asthma COPD overlap a distinct entity
Management of ACO
Asthma and specific conditions and populations
Asthma and pregnancy
Asthma in the elderly
Managing Allergy & Asthma in Resource Poor Settings
Asthma in the obese
Occupational asthma
Asthma co-morbidities
Asthma and rhinitis
Asthma and upper airways dysfunction
Obesity and asthma
Chronic Rhinosinusitis and T2 inflammation
Asthma and nasal polyps
Asthma diagnosis
Under and overtreatment of asthma
Standards for the diagnosis of asthma
Pulmonary function tests
Asthma epidemiology
Incidence and prevalence of asthma in the world
Morbidity and mortality from asthma
Natural history of severe asthma: can it be altered
Asthma pathophysiology
Airway inflammation subtypes
Biomarkers
Airway remodeling
Asthma phenotypes
Asthma phenotyping
Severe asthma
Occupational asthma
Exercise-induced asthma and asthma in the athlete
Eosinophilic asthma
Non-eosinophilic asthma
T2 vs Non-T2 asthma
Obesity and asthma
Asthma treatment
Care gaps
Management of mild asthma
New asthma guidelines
New inhalers
Future treatment of asthma
Non-pharmacologic asthma therapies
Non-biologic treatments for asthma
Impact of new Asthma Biologicals on Asthma Outcomes
Is there still a role of OCS in long-term treatment of severe asthma ?
Is there still a role of SABAs in long-term treatment of severe asthma ?
Clinical aspects of asthma: the patient perspective
Perception of asthma symptoms
Asthma education
Drugs for asthma and COPD
β2-agonists
Inhaled corticosteroids
Anti-cholinergics
Leukotriene antagonists
Combination therapies (double and triple therapy)
Monoclonal antibodies
Environmental factors and asthma
Allergens
Workplace inhalants
Air pollution
Climate change
GINA update
New GINA report in adolescent and adults
New GINA report in children
GINA recommendations on severe asthma
Non-invasive airway inflammation assessment
The role of inflammometry in asthma
Blood and Induced sputum analysis
Exhaled NO measures
Precision medicine
Personalized medicine: how to make it happen
Biomarkers of asthma
Targeting asthma therapy
IL5 versus IgE as a Therapeutics target in Asthma
Anti-IgE
Anti-IL5
Anti-IL4-IL-13
Other cytokines antagonists
COVID-19 and other respiratory infections and asthma
The COVID Pandemic and asthma
Severe COVID pneumonia management
Other Bacterial and Viral infections
Vaccination
Risk factors of asthma
Vitamin deficiency and nutritional factors
Smoking (direct and secondary)
Exposure to bacteria (microbiome)
Genetic factors
Severe asthma
Assessment of severe asthma
Management of difficult-to-control asthma
Severe pediatric asthma
New monoclonal antibodies
Can we predict response to therapies
New therapies to come
Various topics on asthma
History of asthma and its treatment
Conditions mimicking asthma
RCTs or Real-life trials ?
WHO-GARD, ARIA and ISAR initiatives
Surveys of biologics use in asthma